N

NsGene A/S

13 employees

NsGene develops products for the treatment of neurological, alzheimer’s, and parkinson's disease and sensorineural hearing loss.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neuroscience
Developing novel biologics and delivery methods for the treatment of neurological disorders.
Biopharma

Date founded

1999

Funding rounds raised

Total raised

$5.1M

from 3 investors over 3 rounds

N

NsGene A/S raised $5.1M on May 2, 2005

Investors: LD Fonde, Vækstfonden and Karolinska Development

FAQ